Single‐Cell Analysis Clarifies Pathological Heterogeneity in Tenosynovial Giant Cell Tumor and Identifies Biomarkers for Predicting Disease Recurrence
Authors:
Open Access
- 24 March 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (26) , e2415835
Abstract
Diffuse‐type tenosynovial giant cell tumor (D‐TGCT) and localized‐type tenosynovial giant cell tumor (L‐TGCT) share common genomic aberrations and histopathological features, but the former has a more aggressive nature and a higher recurrence rate, leading to worse prognoses for patients. In this study, single‐cell RNA sequencing (scRNA‐seq) on human D‐TGCT and L‐TGCT lesions is conducted to discover transcriptional differences. A unique cluster of tumor cells in D‐TGCT is identified that regulated differentiation of CD34 + fibroblasts into MMP 3 + fibroblasts or APOE + fibroblasts via COL6A3 − (ITGAV + ITGB8) interaction. The APOE + fibroblasts further activated IL‐1B + CCL20 + macrophages through the CXCL12/CXCR4 axis. IL‐1B + CCL20 + macrophages and MMP3 + fibroblasts participated in local aggression of D‐TGCT. Two effective biomarkers, ROR1 and PRKD1 are also identified and validated, to predict disease recurrence. This study not only clarified the underlying mechanisms of aggressive behavior in D‐TGCT but also provided a theoretical basis and potential targets for intervention into and treatment of this disease.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC2705900)
- National Natural Science Foundation of China (82172447)
- National Natural Science Foundation of China (82302746)
This publication has 73 references indexed in Scilit:
- The evolving tumor microenvironment: From cancer initiation to metastatic outgrowthCancer Cell, 2023
- Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancerCancer Cell, 2021
- Management of Pigmented Villonodular Synovitis (PVNS): an Orthopedic Surgeon’s PerspectiveCurrent Oncology Reports, 2020
- Pexidartinib: First ApprovalDrugs, 2019
- Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutationsInternational Journal of Cancer, 2019
- ROR1, an embryonic protein with an emerging role in cancer biologyProtein & Cell, 2014
- Long‐term outcome of the treatment of high‐risk tenosynovial giant cell tumor/pigmented villonodular synovitis with radiotherapy and surgeryCancer, 2012
- Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapyInternational Journal of Cancer, 2008
- Analysis of pigmented villonodular synovitis with genome‐wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approachesArthritis & Rheumatism, 2006
- Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: A clinicopathologic and flow cytometric DNA analysisHuman Pathology, 1992